Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | F7 | P08709 | 2/20 | 0.46 |
| ▸ | F3 | P13726 | 2/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | FABP3 | P05413 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | FABP4 | P15090 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | GNA15 | P30679 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20912483 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CNR1CNR2TRPV1F7 | |
| SCHEMBL20912484 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CNR1CNR2TRPV1F7 | |
| SCHEMBL34463873 | 0.94 | FAAH (0.47) | ALDH1A1CNR1CNR2TRPV1DUSP3 | |
| SCHEMBL10390187 | 0.91 | FAAH (0.42) | ALDH1A1CNR1CNR2TRPV1F7 | |
| SCHEMBL10390188 | 0.91 | FAAH (0.42) | ALDH1A1CNR1CNR2TRPV1F7 | |
| SCHEMBL6436391 | 0.91 | FAAH (0.47) | ALDH1A1CNR1CNR2TRPV1DUSP3 | |
| SCHEMBL6436392 | 0.91 | FAAH (0.47) | ALDH1A1CNR1CNR2TRPV1DUSP3 | |
| SCHEMBL26650545 | 0.89 | FAAH (0.41) | ALDH1A1CNR1CNR2TRPV1F7 | |
| SCHEMBL20536247 | 0.88 | ALDH1A1 (0.53) | ALDH1A1CNR1CNR2TRPV1 | |
| SCHEMBL7753870 | 0.87 | ALDH1A1 (0.46) | ALDH1A1CNR1CNR2F7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108727170-B | 1-halo-6, 9-pentadecadienes and process for preparing (7Z,10Z) -7, 10-hexadecadienals | 信越化学工业株式会社 | 2021-10-26 | — | — | CN | disclosed |
| EP-3392231-B1 | 1-HALO-6,9-PENTADECADIENE AND METHOD FOR PRODUCING (7Z,10Z)-7,10-HEXADECADIENAL | SHINETSU CHEMICAL CO (JP) | 2019-04-24 | — | — | EP | disclosed |
| US-10138191-B2 | 1-halo-6,9-pentadecadiene and method for producing (7Z,10Z)-7,10-hexadecadienal | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-11-27 | — | — | US | disclosed |
| US-20180305284-A1 | 1-HALO-6,9-PENTADECADIENE AND METHOD FOR PRODUCING (7Z,10Z)-7,10-HEXADECADIENAL | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-10-25 | — | — | US | disclosed |
| EP-3392231-A1 | 1-HALO-6,9-PENTADECADIENE AND METHOD FOR PRODUCING (7Z,10Z)-7,10-HEXADECADIENAL | Shin-Etsu Chemical Co., Ltd. (JP) | 2018-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180305284-A1 | 1-HALO-6,9-PENTADECADIENE AND METHOD FOR PRODUCING (7Z,10Z)-7,10-HEXADECADIENAL | HDHD5, OSR1, CYP8B1 | ALDH1A1 1017/4885CNR1 3038/4885CNR2 3914/4885 |
| US-10138191-B2 | 1-halo-6,9-pentadecadiene and method for producing (7Z,10Z)-7,10-hexadecadienal | HDHD5, OSR1, CYP8B1 | ALDH1A1 1017/4885CNR1 3038/4885CNR2 3914/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.